Cibus, Inc. (CBUS)
NASDAQ: CBUS · IEX Real-Time Price · USD
15.54
+0.28 (1.83%)
At close: Apr 25, 2024, 4:00 PM
15.55
+0.01 (0.06%)
After-hours: Apr 25, 2024, 4:20 PM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $384.85 million as of April 26, 2024. Its market cap has increased by 2,415.38% in one year.
Market Cap
384.85M
Enterprise Value
542.03M
1-Year Change
2,415.38%
Ranking
Category
Stock Price
$15.54
Market Cap Chart
Since July 20, 2017, Cibus's market cap has increased from $288.70M to $384.85M, an increase of 33.31%. That is a compound annual growth rate of 4.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 368.30M | -4.56% |
Apr 23, 2024 | 385.90M | -0.05% |
Apr 22, 2024 | 386.10M | 7.37% |
Apr 19, 2024 | 359.60M | -5.22% |
Apr 18, 2024 | 379.40M | 0.72% |
Apr 17, 2024 | 376.70M | -4.00% |
Apr 16, 2024 | 392.40M | -3.44% |
Apr 15, 2024 | 406.40M | -4.76% |
Apr 12, 2024 | 426.70M | -3.11% |
Apr 11, 2024 | 440.40M | -1.52% |
Apr 10, 2024 | 447.20M | -10.25% |
Apr 9, 2024 | 498.30M | 2.68% |
Apr 8, 2024 | 485.30M | 1.25% |
Apr 5, 2024 | 479.30M | 0.31% |
Apr 4, 2024 | 477.80M | -0.21% |
Apr 3, 2024 | 478.80M | -2.54% |
Apr 2, 2024 | 491.30M | -0.06% |
Apr 1, 2024 | 491.60M | -9.30% |
Mar 28, 2024 | 542.00M | 3.16% |
Mar 27, 2024 | 525.40M | -4.59% |
Mar 26, 2024 | 550.70M | 6.39% |
Mar 25, 2024 | 517.60M | 5.25% |
Mar 22, 2024 | 491.80M | 9.09% |
Mar 21, 2024 | 450.80M | 2.88% |
Mar 20, 2024 | 438.20M | 3.37% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lexeo Therapeutics | 399.98M |
Contineum Therapeutics | 399.83M |
NeuroPace | 397.11M |
Lexicon Pharmaceuticals | 396.44M |
Corbus Pharmaceuticals Holdings | 396.01M |
MaxCyte | 395.69M |
Replimune Group | 394.11M |
iTeos Therapeutics | 393.92M |